FADD and lung carcinoma: In lung cancer, it has been demonstrated that increased levels of nuclear phosphorylated FADD induce NF-κB, which is suggested to induce the expression of cyclin D1 (CCND1) at the transcriptional level, ultimately resulting in cell cycle deregulation [5].